I can fairly be faulted for giving too much attention to bad judicial rulings and not enough attention to excellent ones. In an effort to remedy that fault, I am pleased to highlight Fourth Circuit ...

In this 30th anniversary year of MD&DI, the federal preemption provision in the Medical Device Amendments of 1976—an exceptional achievement of the device industry—is still unsettled. No other ...

At a Friday hearing, U.S. District Judge M. Casey Rodgers, of the Northern District of Florida, ordered supplemental briefs to Pfizer's summary judgment motion on federal preemption in light of the ...

A patient prepares to take the first of two combination pills, mifepristone, for a medication abortion during a visit to a clinic in Kansas City, Kan., in October 2022. A federal appeals court has ...

Nearly one year after the U.S. Food and Drug Administration issued a pre-emption on filing failure-to-warn actions over federally approved drugs, rulings across the nation show a clear division over ...

People who believe they were injured by drugs approved by the Food and Drug Administration should not be allowed to sue drug companies in state courts, the agency said yesterday in a formal policy ...